Indies Pharma Jamaica Limited (JMSE: INDIES)

Market Cap	4.58B
Revenue (ttm)	1.16B
Net Income (ttm)	221.18M
Shares Out	1.33B
EPS (ttm)	0.17
PE Ratio	20.72
Forward PE	n/a
Dividend	0.11 (3.20%)
Ex-Dividend Date	Jul 15, 2024

Volume	49,741
Open	n/a
Previous Close	3.200
Day's Range	3.100 - 3.390
52-Week Range	2.250 - 3.440
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 13, 2024

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 71
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In 2024, Indies Pharma Jamaica's revenue was 1.16 billion, an increase of 9.81% compared to the previous year's 1.06 billion. Earnings were 221.18 million, an increase of 3.81%.